Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

April 30 - May 3, 2017
Manchester Grand Hyatt San Diego,
San Diego, CA

THE LARGEST MEETING TO ACCELERATE OLIGONUCLEOTIDE AND PEPTIDE PRODUCTS FROM EARLY DISCOVERY TO LATE-STAGE DEVELOPMENT & COMMERCIALIZATION

Registration Savings Deadline

Receive a $200 savings if you register by Friday, March 31.

TIDES Offers the Science, Technologies and Partners You Need to Grow Your Business

850+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES

Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.

125+ CASE STUDIES AND NEW DATA PRESENTATIONS

Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.

90+ EXHIBITORS

Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.

40+ PEER-SUBMITTED POSTERS

Stay at the forefront of oligonucleotide and peptide innovation by accessing cutting-edge data from fellow attendees.

TIDES Tube is Live!


TIDES Tube provides the global oligonucleotide and peptide community with exclusive video content designed to help accelerate promising therapeutics from early discovery to late-stage development & commercialization.

Check out TIDES Tube now to watch video of last year's keynote presentations.

Do you want to highlight your company's expertise in TIDES Tube?  Contact us today!

cross-fertilize ideas and best practices with researchers from different disciplines

Oligonucleotide Tracks
  • Chemistry, Manufacturing & Controls: Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
  • Discovery, Preclinical and Clinical: Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
  • Nonclinical Development of Oligonucleotides: Hear nonclinical case studies of oligonucleotide therapeutics that share strategies to help you optimize the ADME and safety properties of your molecules and overcome nonclinical development challenges.
Peptide Tracks
  • Chemistry, Manufacturing & Controls: Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
  • Discovery, Preclinical and Clinical: Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
New! mRNA and CRISPR Therapeutics
  • Learn industry best practices for overcoming delivery and regulatory challenges, advance mRNA and CRISPR therapeutics into Phase 1, 2, and 3 clinical trials, and optimize the properties of your complex molecules.

TIDES 2016 Highlight Video


See what attendees at TIDES 2016 had to say about their onsite experience!

Present a Scientific Poster at TIDES 2017


Highlight your company's latest research findings by presenting a scientific poster, which will be displayed in the exhibit & poster hall during the event. The deadline to submit your poster is March 31, 2017.

Connect with Key Buyers at TIDES 2017 in San Diego, CA